KG
RMD icon

Kilter Group’s ResMed RMD Stock Holding History

Kilter Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.61K Buy
25
+5
+25% +$1.25K ﹤0.01% 579
2025
Q4 		$4.82K Sell
20
-4
-17% -$1.02K ﹤0.01% 517
2025
Q3 		$6.57K Buy
24
+8
+50% +$2.19K ﹤0.01% 406
2025
Q2 		$4.13K Buy
+16
New +$3.82K ﹤0.01% 447

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Kilter Group's RMD Position: Q1 2026 in Review

Kilter Group increased its ResMed (RMD) stake by 25% in Q1 2026, buying an estimated $1.25K and bringing the position to 25 shares worth $5.61K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

Kilter Group first reported a position in RMD in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.57K in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Kilter Group held 25 shares of ResMed worth $5.61K as of Q1 2026.
  • Kilter Group bought 5 ResMed shares in Q1 2026, an estimated $1.25K.
  • ResMed made up ﹤0.01% of Kilter Group's portfolio in Q1 2026, its #579 holding.
  • Kilter Group first reported a position in ResMed in Q2 2025 and has held it in 4 quarters since.
  • Kilter Group's ResMed position peaked at $6.57K in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Kilter Group's 13F filing for Q1 2026, filed 14 May 2026.